Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance
Main Authors: | Marta Barisa, Daniel Abate-Daga, Jonathan Fisher |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1414812/full |
Similar Items
-
Preclinical platforms to study therapeutic efficacy of human γδ T cells
by: Lingling Ou, et al.
Published: (2022-06-01) -
Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
by: Guang-Long Ma, et al.
Published: (2023-04-01) -
γδ T cells in 3D culture: The potential use in the therapeutics development
by: Shih‐Han Wang, et al.
Published: (2022-06-01) -
Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
by: Alexander Piening, et al.
Published: (2022-12-01) -
A Comprehensive Benchmark of Transcriptomic Biomarkers for Immune Checkpoint Blockades
by: Hongen Kang, et al.
Published: (2023-08-01)